CRIS Current Research Information System

FOLLO, MATILDE YUNG

FOLLO, MATILDE YUNG  

DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE  

Docenti di ruolo di Ia fascia  

M. Follo; Matilde Y. Follo; F. Matilde; MY Follo; FOLLO MY  

Mostra records
Risultati 1 - 20 di 128 (tempo di esecuzione: 0.023 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y 2023-01-01 CLINICAL EPIGENETICS - 1.01 Articolo in rivista s13148-023-01441-9.pdf; 13148_2023_1441_MOESM2_ESM.pdf; 13148_2023_1441_MOESM3_ESM (1).pdf; 13148_2023_1441_MOESM1_ESM.xlsx
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Lib...ra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA. 2019-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. S.M. Akula, S. Candido, M. Libra, S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, G. Ramazzotti, S.... Ratti, M.Y. Follo, A.M. Martelli, R.M. Murata, P.L. Rosalen, B. Bueno-Silva, S. Matias de Alencar, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, H.-L. Lin, P. Lombardi, J.A. McCubrey. 2019-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; R...atti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A. 2020-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Advances in MDS/AML and inositide signalling De Stefano A.; Marvi M.V.; Fazio A.; McCubrey J.A.; Suh P.G.; Ratti S.; Ramazzotti G.; Manzoli L....; Cocco L.; Follo M.Y. 2023-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza;... Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. 2015-01-01 JOURNAL OF LEUKOCYTE BIOLOGY - 1.01 Articolo in rivista -
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L;
Baccarani M 		2011-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L;
Martinelli G; Cocco L; Baccarani M 		2012-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo 2011-01-01 LEUKEMIA RESEARCH - 4.02 Riassunto (Abstract) -
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo 2010-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-03498-v3(1).pdf
Cancer therapy and treatments during COVID-19 era Akula S.M.; Abrams S.L.; Steelman L.S.; Candido S.; Libra M.; Lerpiriyapong K.; Cocco L.; Ramazzo...tti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Blalock W.L.; Piazzi M.; Montalto G.; Cervello M.; Notarbartolo M.; Basecke J.; McCubrey J.A. 2020-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M....; Cocco L.; Follo M.Y.; Manzoli L. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-00827-v2.pdf
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio 2016-01-01 CURRENT PHARMACEUTICAL DESIGN - 1.01 Articolo in rivista -
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta
M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli 2013-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco 2013-01-01 BLOOD - 4.01 Contributo in Atti di convegno -